Comparison of clinical characteristics between meth/amphetamine and synthetic cathinone users presented to the emergency department

References

• Guirguis A. New psychoactive substances: a public health issue. Int J Pharm Pract. 2017;25(5):323–325.
   PubMed Web of Science ®Google Scholar
• Goncalves JL, Alves VL, Aguiar J, et al. Synthetic cathinones: an evolving class of new psychoactive substances. Crit Rev Toxicol. 2019;49(7):549–566.
   PubMed Web of Science ®Google Scholar
• UNODC. What are NPS? 2021. [cited 2022 Jan 21]. Available from: https://www.unodc.org/LSS/Page/NPS.
   Google Scholar
• German CL, Fleckenstein AE, Hanson GR. Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sci. 2014;97(1):2–8.
   PubMed Web of Science ®Google Scholar
• Megarbane B, Oberlin M, Alvarez JC, et al. Management of pharmaceutical and recreational drug poisoning. Ann Intensive Care. 2020;10(1):157.
   PubMed Web of Science ®Google Scholar
• Wood DM, Ceronie B, Dargan PI. Healthcare professionals are less confident in managing acute toxicity related to the use of new psychoactive substances (NPS) compared with classical recreational drugs. QJM. 2016;109(8):527–529.
   PubMed Web of Science ®Google Scholar
• La Maida N, Di Trana A, Giorgetti R, et al. A review of synthetic cathinone-related fatalities from 2017 to 2020. Ther Drug Monit. 2021;43(1):52–68.
   PubMed Web of Science ®Google Scholar
• Chen HY, Chien WC, Huang MN, et al. Analytically confirmed eutylone (bk-EBDB) exposure in emergency department patients. Clin Toxicol. 2021;59(9):846–848.
   PubMed Web of Science ®Google Scholar
• Luethi D, Liechti ME. Designer drugs: mechanism of action and adverse effects. Arch Toxicol. 2020;94(4):1085–1133.
   PubMed Web of Science ®Google Scholar
• O'Connor AD, Padilla-Jones A, Gerkin RD, et al. Prevalence of rhabdomyolysis in sympathomimetic toxicity: a comparison of stimulants. J Med Toxicol. 2015;11(2):195–200.
   PubMed Web of Science ®Google Scholar
• Prosser JM, Nelson LS. The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol. 2012;8(1):33–42.
   PubMedGoogle Scholar
• Borek HA, Holstege CP. Hyperthermia and multiorgan failure after abuse of “bath salts” containing 3,4-methylenedioxypyrovalerone. Ann Emerg Med. 2012;60(1):103–105.
   PubMed Web of Science ®Google Scholar
• Beck O, Backberg M, Signell P, et al. Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats. Clin Toxicol. 2018;56(4):256–263.
   PubMed Web of Science ®Google Scholar
• Feng LY, Li JH. New psychoactive substances in Taiwan: challenges and strategies. Curr Opin Psychiatry. 2020;33(4):306–311.
   PubMed Web of Science ®Google Scholar
• Ling DA, Weng TI, Chen JY, et al. Clinical manifestation and quantitative urinary analysis of N-ethylnorpentylone abuse in patients to the emergency department. Clin Toxicol. 2020;58(9):935–937.
   PubMed Web of Science ®Google Scholar
• Chou HH, Hsieh CH, Chaou CH, et al. Synthetic cathinone poisoning from ingestion of drug-laced “instant coffee packets” in Taiwan. Hum Exp Toxicol. 2021;40(9):1403–1412.
   PubMed Web of Science ®Google Scholar
• Weng TI, Su PI, Chen JY, et al. Analytically confirmed 4-Methyl-N-ethylnorpentedrone (4-MEAP), a synthetic cathinone, in cases presenting to an emergency department. Clin Toxicol. 2020;58(1):65–66.
   PubMed Web of Science ®Google Scholar
• Chen JY, Chen GY, Wang SY, et al. Development of an analytical method to detect simultaneously 219 new psychoactive substances and 65 other substances in urine specimens using LC-QqQ MS/MS with CriticalPairFinder and TransitionFinder. Talanta. 2022;238(Pt 1):122979.
   PubMedGoogle Scholar
• Lin CC, Weng TI, Ng CJ, et al. Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan emergency department drug abuse surveillance (TEDAS) project. Clin Toxicol. 2022:1–8. DOI:http://doi.org/10.1080/15563650.2022.2038793
   Google Scholar
• Weaver MF, Hopper JA, Gunderson EW. Designer drugs 2015: assessment and management. Addict Sci Clin Pract. 2015;10:8.
   PubMed Web of Science ®Google Scholar
• Hill SL, Thomas SH. Clinical toxicology of newer recreational drugs. Clin Toxicol. 2011;49(8):705–719.
   Web of Science ®Google Scholar
• Valente MJ, Guedes de Pinho P, de Lourdes Bastos M, et al. Khat and synthetic cathinones: a review. Arch Toxicol. 2014;88(1):15–45.
   PubMed Web of Science ®Google Scholar
• Martinez-Clemente J, Lopez-Arnau R, Carbo M, et al. Mephedrone pharmacokinetics after intravenous and oral administration in rats: relation to pharmacodynamics. Psychopharmacology. 2013;229(2):295–306.
   PubMed Web of Science ®Google Scholar
• Simmler LD, Buser TA, Donzelli M, et al. Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol. 2013;168(2):458–470.
   PubMed Web of Science ®Google Scholar
• Papaseit E, Perez-Mana C, Mateus JA, et al. Human pharmacology of mephedrone in comparison with MDMA. Neuropsychopharmacology. 2016;41(11):2704–2713.
   PubMed Web of Science ®Google Scholar
• Bowyer JF, Hanig JP. Amphetamine- and methamphetamine-induced hyperthermia: Implications of the effects produced in brain vasculature and peripheral organs to forebrain neurotoxicity. Temperature. 2014;1(3):172–182.
   PubMedGoogle Scholar
• Rusyniak DE, Sprague JE. Toxin-induced hyperthermic syndromes. Med Clin North Am. 2005;89(6):1277–1296.
   PubMed Web of Science ®Google Scholar
• Forrester MB. Adolescent synthetic cathinone exposures reported to Texas poison centers. Pediatr Emerg Care. 2013;29(2):151–155.
   PubMed Web of Science ®Google Scholar
• Kiyatkin EA, Kim AH, Wakabayashi KT, et al. Effects of social interaction and warm ambient temperature on brain hyperthermia induced by the designer drugs methylone and MDPV. Neuropsychopharmacology. 2015;40(2):436–445.
   PubMed Web of Science ®Google Scholar
• Anneken JH, Angoa-Pérez M, Kuhn DM. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter. J Neurochem. 2015;133(2):211–222.
   PubMed Web of Science ®Google Scholar
• Fantegrossi WE, Gannon BM, Zimmerman SM, et al. In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity. Neuropsychopharmacology. 2013;38(4):563–573.
   PubMed Web of Science ®Google Scholar
• Zaretsky DV, Brown MB, Zaretskaia MV, et al. The ergogenic effect of amphetamine. Temperature. 2014;1(3):242–247.
   PubMedGoogle Scholar
• Soares J, Costa VM, Bastos ML, et al. An updated review on synthetic cathinones. Arch Toxicol. 2021;95(9):2895–2940.
   PubMed Web of Science ®Google Scholar
• Marusich JA, Antonazzo KR, Wiley JL, et al. Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology. 2014;87:206–213.
   PubMed Web of Science ®Google Scholar
• Baumann MH, Partilla JS, Lehner KR, et al. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products. Neuropsychopharmacology. 2013;38(4):552–562.
   PubMed Web of Science ®Google Scholar
• Varner KJ, Daigle K, Weed PF, et al. Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats. Psychopharmacology. 2013;225(3):675–685.
   PubMed Web of Science ®Google Scholar
• Weng TI, Chen LY, Chen JY, et al. Characteristics of analytically confirmed illicit substance-using patients in the emergency department. J Formos Med Assoc. 2020;119(12):1827–1834.
   PubMed Web of Science ®Google Scholar
• Helander A, Backberg M, Hulten P, et al. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project. Forensic Sci Int. 2014;243:23–29.
   PubMed Web of Science ®Google Scholar
• George MD, McGill NK, Baker JF. Creatine kinase in the U.S. population: Impact of demographics, comorbidities, and body composition on the normal range. Medicine. 2016;95(33):e4344.
   PubMed Web of Science ®Google Scholar
• Romanek K, Stenzel J, Schmoll S, et al. Synthetic cathinones in Southern Germany – characteristics of users, substance-patterns, co-ingestions, and complications. Clin Toxicol. 2017;55(6):573–578.
   PubMed Web of Science ®Google Scholar
• Schifano F, Corkery J, Ghodse AH. Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, “meow meow”) in the United Kingdom. J Clin Psychopharmacol. 2012;32(5):710–714.
   PubMed Web of Science ®Google Scholar